These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 28403947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction.
    Wang LL, Guo HH, Huang S, Feng CL, Han YX, Jiang JD.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul 01; 1057():70-80. PubMed ID: 28505492
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
    Guo Y, Zhang Y, Huang W, Selwyn FP, Klaassen CD.
    BMC Complement Altern Med; 2016 Oct 18; 16(1):394. PubMed ID: 27756364
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Effects of Berberine on the Gut Microbiota in Apc min/+ Mice Fed with a High Fat Diet.
    Wang H, Guan L, Li J, Lai M, Wen X.
    Molecules; 2018 Sep 08; 23(9):. PubMed ID: 30205580
    [Abstract] [Full Text] [Related]

  • 11. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y, Hu J, Geng J, Hu T, Wang B, Yan W, Jiang Y, Li J, Liu S.
    Biomed Pharmacother; 2018 Nov 08; 107():1556-1563. PubMed ID: 30257374
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
    Yue SJ, Liu J, Wang AT, Meng XT, Yang ZR, Peng C, Guan HS, Wang CY, Yan D.
    Am J Physiol Endocrinol Metab; 2019 Jan 01; 316(1):E73-E85. PubMed ID: 30422704
    [Abstract] [Full Text] [Related]

  • 17. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
    Xiao S, Zhang Z, Chen M, Zou J, Jiang S, Qian D, Duan J.
    J Ethnopharmacol; 2019 Sep 15; 241():112032. PubMed ID: 31220598
    [Abstract] [Full Text] [Related]

  • 18. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
    Chen H, Zhang F, Zhang J, Zhang X, Guo Y, Yao Q.
    Front Immunol; 2020 Sep 15; 11():588079. PubMed ID: 33072135
    [Abstract] [Full Text] [Related]

  • 19. Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats.
    Huang M, He Y, Tian L, Yu L, Cheng Q, Li Z, Gao L, Gao S, Yu C.
    J Affect Disord; 2023 Mar 15; 325():141-150. PubMed ID: 36610597
    [Abstract] [Full Text] [Related]

  • 20. Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation.
    Tian Y, Cai J, Gui W, Nichols RG, Koo I, Zhang J, Anitha M, Patterson AD.
    Drug Metab Dispos; 2019 Feb 15; 47(2):86-93. PubMed ID: 30409838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.